Ziprasidone Hydrochloride
13 NDCs across 4 manufacturers|13 Generic,0 Brand
Ziprasidone Hydrochloride is used to treat schizophrenia and tourette syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 5, 2001, and the first generic was approved Mar 2, 2012. FDA's Orange Book lists 32 AB-rated (therapeutically equivalent) products for this ingredient.
Ziprasidone Hydrochloride is available as 13 NDCs from 4 manufacturers (13 generic, 0 brand), with NADAC prices from $0.27 to $0.32 per EA — a 17% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
13
13G / 0B
Manufacturers
4
competing in market
Price Spread
$0.27 – $0.32
per EA
7d Activity
avg -4.8% WoW · of 13 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Macleods Pharmaceuticals Limited manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Atypical Antipsychotic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing ZIPRASIDONE HYDROCHLORIDE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZIPRASIDONE HCL 80 MG CAPSULE | $0.3157 per EA | -6.37% |
ZIPRASIDONE HCL 80 MG CAPSULE | $0.3157 per EA | -6.37% |
ZIPRASIDONE HCL 80 MG CAPSULE | $0.3157 per EA | -6.37% |
ZIPRASIDONE HCL 60 MG CAPSULE | $0.3140 per EA | -4.67% |
ZIPRASIDONE HCL 60 MG CAPSULE | $0.3140 per EA | -4.67% |
ZIPRASIDONE HCL 60 MG CAPSULE | $0.3140 per EA | -4.67% |
ZIPRASIDONE HCL 40 MG CAPSULE | $0.2722 per EA | +1.91% |
ZIPRASIDONE HCL 40 MG CAPSULE | $0.2722 per EA | +1.91% |
ZIPRASIDONE HCL 40 MG CAPSULE | $0.2722 per EA | +1.91% |
ZIPRASIDONE HCL 40 MG CAPSULE | $0.2702 per EA | — |
ZIPRASIDONE HCL 20 MG CAPSULE | $0.2694 per EA | -9.87% |
ZIPRASIDONE HCL 20 MG CAPSULE | $0.2694 per EA | -9.87% |
ZIPRASIDONE HCL 20 MG CAPSULE | $0.2694 per EA | -9.87% |
Frequently Asked Questions
What is Ziprasidone Hydrochloride used to treat?
Ziprasidone Hydrochloride is used to treat schizophrenia and tourette syndrome, per the National Library of Medicine's MED-RT classification.
When did Ziprasidone Hydrochloride become available as a generic?
FDA approved the first generic Ziprasidone Hydrochloride (ANDA) on Mar 2, 2012. The Orange Book currently lists 32 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Ziprasidone Hydrochloride products are on the market?
The Ziprasidone Hydrochloride drug market contains 13 NDCs from 4 manufacturers — 13 generic and 0 brand products.
What is the price range for Ziprasidone Hydrochloride?
NADAC reference prices for Ziprasidone Hydrochloride range from $0.2694 to $0.3157 per EA — a 17% difference between cheapest and most expensive.
Which manufacturers make Ziprasidone Hydrochloride?
4 manufacturers list Ziprasidone Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Macleods Pharmaceuticals Limited (4), BluePoint Laboratories (4), Aurobindo Pharma Limited (4), McKesson (1).
How has the price of Ziprasidone Hydrochloride changed recently?
Over the past 7 days, 3 Ziprasidone Hydrochloride NDCs rose and 9 fell, with a market-wide average change of -4.8%.